Textile article for patients affected by a skin disease

Abstract

Textile article, for example a garment, particularly an under-garment, or bed linen, for patients affected by a skin disease, said article comprising at least one textile layer comprising polytetrafluoroethylene (PTFE) fibres, said fibres being present at least at one surface of the textile layer intended to be in contact with the patient's skin. The PTFE fibres make it possible to obtain a very smooth surface, which is not sticky in the least and provides a pleasing sensation of freshness and slipperiness.

1 . Textile article for patients affected by a skin disease, said article comprising at least one textile layer comprising polytetrafluoroethylene (PTFE) fibres, said fibres being present at least at one surface of the textile layer intended to be in contact with the patient's skin. 
     
     
         2 . Article according to  claim 1 , wherein said skin disease is psoriasis or atopic dermatitis. 
     
     
         3 . Article according to  claim 1 , said article being selected from: garments, particularly under-garments; bed linen. 
     
     
         4 . Article according to  claim 1 , wherein the PTFE fibres are in the form of continuous fibre yarns. 
     
     
         5 . Article according to  claim 1 , wherein the PTFE fibres are in the form of discontinuous fibre yarns, intimately commingled with other fibres, such as cotton or wool, wherein the amount of PTFE fibres is preferably not lower than 20% by weight of the whole yarn. 
     
     
         6 . Article according to  claim 1 , wherein said at least one textile layer is a fabric having a warp-weft structure. 
     
     
         7 . Article according to  claim 1 , wherein said at least one textile layer is a knitted fabric. 
     
     
         8 . Article according to  claim 1 , wherein said at least one textile layer is formed by 100% PTFE fibres. 
     
     
         9 . Article according to  claim 1 , wherein in said at least one textile layer the PTFE fibres are combined with fibre of a different type, either natural (e.g. cotton) or artificial (e.g. cellulosic), or synthetic (e.g. polyesters or polyamides). 
     
     
         10 . Article according to  claim 9 , wherein said at least one textile layer has a warp-weft structure having a weaving such as to obtain a double face fabric wherein the PTFE fibre is mainly present at the internal face, while the other fibre is mainly present at the exterior. 
     
     
         11 . Article according to  claim 1 , wherein, at the surface of the textile layer intended to be in contact with the patient's skin, the percentage of PTFE fibres is comprised from 60% to 100%, more preferably from 70 to 100%. 
     
     
         12 . A textile article comprising at least one textile layer comprising polytetrafluoroethylene (PTFE) fibres to alleviate symptoms and/or improve disease course in a patient affected by a skin disease, said fibres being present at least at one surface of the textile layer intended to be in contact with the patient's skin. 
     
     
         13 . Article according to  claim 12 , wherein said skin disease is psoriasis or atopic dermatitis. 
     
     
         14 . Article according to  claim 12 , wherein said textile article comprises at least one of:
 (a) said article being selected from: garments, particularly under-garments; bed linen,   (b) wherein the PTFE fibres are in the form of continuous fibre yarns,   (c) wherein the PTFE fibres are in the form of discontinuous fibre yarns, intimately commingled with other fibres, such as cotton or wool, wherein the amount of PTFE fibres is preferably not lower than 20% by weight of the whole yarn,   (d) wherein said at least one textile layer is a fabric having a warp-weft structure,   (e) wherein said at least one textile layer is a knitted fabric,   (f) wherein said at least one textile layer is formed by 100% PTFE fibres,   (g) wherein in said at least one textile layer the PTFE fibres are combined with fibre of a different type, either natural (e.g. cotton), or artificial (e.g. cellulosic), or synthetic (e.g. polyesters or polyamides), and   (h) wherein, at the surface of the textile layer intended to be in contact with the patient's skin, the percentage of PTFE fibres is comprised from 60% to 100%, more preferably from 70 to 100%.